- Conditions
- Short Bowel Syndrome
- Interventions
- Growth Hormone
- Drug
- Lead sponsor
- University of Nebraska
- Other
- Eligibility
- 19 Years to 78 Years
- Enrollment
- 5 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2008
- U.S. locations
- 1
- States / cities
- Omaha, Nebraska
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–30
of 6
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Short Bowel Syndrome
- Interventions
- NM-002
- Drug
- Lead sponsor
- 9 Meters Biopharma, Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020
- U.S. locations
- 1
- States / cities
- Los Angeles, California
- Conditions
- Short Bowel Syndrome, Short Gut Syndrome, SBS, Short Gut
- Interventions
- 0.6 mL, MP-101 (10 mg/mL, Opium Tincture (OT)), USP (Deodorized)
- Drug
- Lead sponsor
- Marathon Pharmaceuticals, LLC
- Industry
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2018
- U.S. locations
- 5
- States / cities
- Chicago, Illinois • Indianapolis, Indiana • Cleveland, Ohio + 2 more
- Conditions
- Short Gut Syndrome
- Interventions
- Green bean puree
- Other
- Lead sponsor
- University of Texas Southwestern Medical Center
- Other
- Eligibility
- 4 Months to 17 Years
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2028
- U.S. locations
- 2
- States / cities
- Dallas, Texas
- Conditions
- Short Bowel Syndrome
- Interventions
- Placebo, Teduglutide 0.05 mg/kg/d, Teduglutide 0.1 mg/kg/d
- Drug
- Lead sponsor
- Shire
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 84 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2007
- U.S. locations
- 14
- States / cities
- Scottsdale, Arizona • Washington D.C., District of Columbia • Atlanta, Georgia + 11 more
- Conditions
- Short Bowel Syndrome
- Interventions
- teduglutide 0.05 mg/kg/d, teduglutide 0.10 mg/kg/d
- Drug
- Lead sponsor
- Shire
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 65 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2008
- U.S. locations
- 9
- States / cities
- Scottsdale, Arizona • Atlanta, Georgia • Omaha, Nebraska + 6 more